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Escherichia coli F-18, an excellent colonizer of the streptomycin-treated mouse large intestine, produces type
1 pili. E. coli F-18 FimA-, type 1 pilus negative, and E. coli F-18 FimH-, type 1 pilus positive but adhesin
negative, were constructed by bacteriophage P1 transduction of defectivefimA andfimH genes from the E. coli
K-12 strains ORN151 and ORN133, respectively, into E. coli F-18. Adhesion of E. coli F-18 to an immobilized
mannose-bovine serum albumin glycoconjugate was about sixfold greater than that of either E. coli F-18
FimA- or E. coli F-18 FimH-, and adhesion of E. coli F-18 to immobilized cecal epithelial cell brush border
membranes was between two- and threefold greater than that of E. coli F-18 FimA- or E. coli F-18 FimH-.
When either E. coli F-18 FimA- or E. coli FimH- was fed to streptomycin-treated mice together with E. coli
F-18, the pilus-negative and adhesin-negative strains colonized as well as their type 1-piliated parent.
Essentially the same result was observed when the type 1-piliated E. coli K-12 strain ORN152 was fed to
streptomycin-treated mice together with a nearly isogenic K-12 FimA- strain, ORN151. Furthermore, when
streptomycin-treated mice were fed E. coli F-18 FimA- or E. coli F-18 FimH- together with E. coli F-18 Col,
which also makes type 1 pili but is a poor colonizer relative to E. coli F-18 because it grows poorly in mucus
in the presence of E. coli F-18, the F-18 FimA- and F-18 FimH- strains colonized well (106 to 107 CFU/g of
feces), whereas the number of E. coli F-18 Col- in feces decreased rapidly to 102 CFU/g of feces. These data
show that in streptomycin-treated mice, the inability to produce functional type 1 pili has no effect on the ability
of E. coli F-18 and E. coli K-12 to colonize the large intestine.
At least 85% of Escherichia coli strains isolated from the
feces of normal humans contain thefim operon (alternatively
called the pil operon), which encodes the genes for type
1-pilus synthesis, and at least 58% express the pilus in broth
(5). Type 1 pili mediate adhesion of E. coli strains to
mannose-containing receptors present on a variety of epithe-
lial cell types, including those in mammalian intestines (10,
35). It has been postulated by various workers that the roles
of type 1 pili in the gastrointestinal tract are to bind to
intestinal epithelial cells and thereby protect the bacteria
from being swept away by normal cleansing mechanisms
(e.g., peristalsis) (11, 48), to offer bacteria adhering to
epithelial cells a growth advantage by being close to the food
supply in the unstirred mucus layer near the epithelial cells
(48), and to allow adhesion to large-intestine mucus (39). If
any or all of these hypotheses are correct, E. coli strains
bearing type 1 pili should be better colonizers of mammalian
large intestines than their non-type 1-piliated counterparts.
E. coli F-18, isolated from the feces of a healthy human, is
an excellent colonizer of the streptomycin-treated mouse
large intestine (7, 33). It is found in both cecal mucus and
cecal contents in vivo but grows only in cecal mucus in vitro
(46), suggesting that it colonizes by growing in cecal mucus
in vivo. Moreover, E. coli F-18 binds to specific glycoprotein
receptors present in cecal and colonic mucus and cecal and
colonic brush border membranes isolated from the respec-
tive epithelial cells (6, 47). Adhesion to these mucosal
components is inhibitable by D-mannose and a-D-methyl
mannoside (47), suggesting that type 1 pili may mediate
adhesion (43). E. coli F-18 is, in fact, piliated (47). Here, we
show that the E. coli F-18 pili are indeed type 1 but that type
* Corresponding author.
1 pili are not necessary for maximal large-intestine coloniz-
ing ability of either E. coli F-18 or E. coli K-12 in strepto-
mycin-treated mice.
MATERIALS AND METHODS
Bacteria. E. coli K-12 strains were all derived from E. coli
ORN115 (30). ORN152 contains a TnS insertion in a silent
region near the fimH (pilE) gene, making it kanamycin
resistant but wild type for type 1 pili. E. coli ORN151
contains the tetracycline resistance gene from TnJO inserted
in thefimA (pilA) gene, making it pilus negative. The strain
will be referred to as ORN151 (FimA-). ORN133 (30)
contains the neomycin phosphotransferase gene from TnS
inserted in the fimH (pilE) gene, making it adhesin negative
and kanamycin resistant (29). It will be referred to as
ORN133 (FimH-). E. coli F-18 was isolated from the feces
of a healthy human in 1977 and is an excellent colonizer of
the streptomycin-treated mouse large intestine (7, 33). The
strain produces colicin V (Dwayne C. Savage, personal
communication), and its serotype is rough:Kl:H5 (Frits
0rskov and Ida 0rskov, personal communication). E. coli
F-18 FimA- and E. coli F-18 FimH- were made by bacte-
riophage P1 transduction from ORN151 (FimA-) and
ORN133 (FimH-), respectively. E. coli F-18 Col- has the
same serotype as E. coli F-18 but lacks an 86-kilobase
plasmid, does not produce the E. coli F-18 colicin, and is a
poor colonizer of the streptomycin-treated mouse large
intestine (7).
P1 transduction. E. coli F-18 is resistant to streptomycin
(Strr) and rifampin (Rif) and grows well in minimal broth
Davis. ORN151 (FimA-) and ORN133 (FimH-) are resistant
to streptomycin, as well as to tetracycline (Tet) and kana-
mycin (Kanr), respectively; however, the ORN strains are
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E. COLI COLONIZATION 3023
polyauxotrophic and do not grow in minimal broth Davis.
ORN151 and ORN133 were lysogenized with Pl::Tn5 (41)
and P1 clr 100 Cm (16), respectively. Lysates were induced
at 42°C and used to infect E. coli F-18 at a multiplicity of
infection of between 1.0 and 5.0. Putative transductants
were selected on Luria agar plates containing 50 jig of
rifampin per ml and 10 ,ug of tetracycline hydrochloride per
ml (for E. coli F-18 FimA-) or on plates containing rifampin
and 40 ,ug of kanamycin monosulfate per ml (for E. coli F-18
FimH-). All putative transductants were found to be lysog-
enized. Four putative E. coli F-18 FimA- transductants
were cured of Pl::Tn5 and four putative E. coli F-18 FimA-
transductants were cured of Pl::Tn5 and four putative E.
coli F-18 FimH- transductants were cured of P1 clr 100 Cm
by growth at 37°C in the presence of sodium citrate (0.5 mM)
to chelate calcium and prevent further P1 infection. All
cured transductants were both Strr and Rif, grew well in
minimal broth Davis, and behaved as FimA- or FimH- both
in binding to a mannose-bovine serum albumin (BSA) gly-
conjugate and in piliation (see Results). One E. coli F-18
FimA- strain and one E. coli F-18 FimH- strain were chosen
for further study.
Mouse colonization experiments. The method used to dis-
tinguish the relative colonizing abilities of E. coli strains in
mice has been described in detail previously (7, 46). Briefly,
after 1 day of being fed streptomycin sulfate in their drinking
water (5 g/liter), three male CD-1 mice were starved from 18
to 24 h for food (Charles River Valley Rat, Mouse, and
Hamster Formula) and water and fed 1010 CFU each of the
L broth-grown E. coli strains to be tested in 1 ml of sterile
20% (wt/vol) sucrose, as described previously (7). The mice
drank the bacterial suspension almost immediately and were
then given food and streptomycin-containing drinking water.
The following day and at 24- or 48-h intervals, as indicated,
fecal samples, no older than 24 h, were collected, homoge-
nized, diluted, and plated on selective media as described
below. In all colonization experiments, plates were incu-
bated at 37°C for 18 to 24 h. Colonizing ability was assessed
by the level at which a strain persisted in feces. Each
experiment was performed at least twice with essentially
identical results.
To differentiate E. coli F-18 (Strr Rif) from E. coli F-18
FimA- (Strr Rif' Tetr), fecal samples were plated on Mac-
Conkey agar containing 10 ,ug of streptomycin sulfate per ml
and 50 ,ug of rifampin per ml and on MacConkey agar
containing 100 ,ug of streptomycin sulfate per ml, 50 ,ug of
rifampin per ml, and 10 p.g of tetracycline hydrochloride per
ml. The numbers of E. coli F-18 FimA- were determined
directly from the plates containing tetracycline hydrochlo-
ride. The numbers of E. coli F-18 were determined each day
by toothpicking 50 colonies from the plates without tetracy-
cline hydrochloride to MacConkey agar plates containing
tetracycline and determining the fraction of the total count
that was tetracycline sensitive. The numbers of E. coli F-18
FimA- per gram of feces calculated from the results of
toothpicking agreed very well with the numbers determined
by direct plating.
To differentiate E. coli F-18 (Strr Rif) from E. coli F-18
FimH- (Strr Rifr Kanr), fecal samples were plated on Mac-
Conkey agar containing 100 ,ug of streptomycin sulfate per
ml and 50 ,ug of rifampin per ml and on MacConkey agar
containing 100 p,g of streptomycin sulfate per ml, 50 ,ug of
rifampin per ml, and 40 jig of kanamycin monophosphate per
ml. The numbers of E. coli F-18 FimH- were determined
directly from the plates containing kanamycin monosulfate.
The numbers of E. coli F-18 were determined each day by
toothpicking 50 colonies from the plates without kanamycin
monosulfate to MacConkey agar containing kanamycin and
determining the fraction of the total count that was kanamy-
cin sensitive. The numbers of E. coli F-18 FimH- per gram
of feces calculated from the results of toothpicking agreed
very well with the numbers determined by direct plating.
To differentiate E. coli F-18 FimA- (Strr Rifr Tetr) from E.
coli F-18 Col- (Strr NalD), fecal samples were plated on
MacConkey agar containing 100 ,ug of streptomycin sulfate
per ml, 50 ,ug of rifampin per ml, and 10 ,ug of tetracycline
hydrochloride per ml and on MacConkey agar containing 100
,ug of streptomycin sulfate per ml and 50 ,ug of nalidixic acid
per ml.
To differentiate E. coli F-18 FimH- (Strr Rif' Kanr) from
E. coli F-18 Col- (Strr Nalr), fecal samples were plated on
MacConkey agar containing 100 ,ug of streptomycin sulfate
per ml, 50 ,ug of rifampin per ml, and 40 ,ug of kanamycin
monosulfate per ml and on MacConkey agar containing 100
,ug of streptomycin sulfate per ml and 50 ,ug of nalidixic acid
per ml.
To differentiate E. coli ORN152 (Strr Kan') from the
FimA- strain E. coli ORN151 (Strr Tet'), fecal samples were
plated on MacConkey agar plates containing 100 ,ug of
streptomycin sulfate per ml and 40 ,ug of kanamycin mono-
sulfate per ml and on MacConkey agar plates containing 100
,ug of streptomycin sulfate per ml and 10 ,ug of tetracycline
hydrochloride per ml.
Cecal brush border membrane preparation. Cecal epithe-
lial cells were isolated from 15 mice as described previously
(47). The final suspensions contained 4.0 x 106 epithelial
cells per ml in 24.5 mM HEPES (N-2-hydroxyethylpipera-
zine-N'-2-ethanesulfonic acid) buffer (pH 7.5) containing 2.5
mM monosodium phosphate and 98 mM sodium chloride.
Brush border membranes were prepared from cecal epithe-
lial cells as described previously (47). Final suspensions,
containing brush borders from 107 epithelial cells per ml,
were in HEPES-Hanks buffer (pH 7.4).
Radioactive labeling of E. coli strains. Cultures of the E.
coli F-18 strains were labeled in modified Davis minimal
medium as described previously (6, 47). 35S04-labeled cul-
tures were washed twice in HEPES-Hanks buffer (pH 7.4) at
4°C and suspended in the same buffer at 37°C at about 109
cells per ml. The specific activity was routinely between 2 x
10-3 and 5 x 10-3 cpm/CFU, depending on the age of the
31SO4. The E. coli ORN strains were labeled in modified
Davis minimal medium supplemented with 2 jxg of thiamine
per ml and 50 pug each of L-arginine, L-leucine, and L-
threonine per ml.
Electron microscopy. Bacterial preparations were grown
overnight in stationary culture at 37°C in brain heart infusion
broth, diluted back 100-fold, grown identically in fresh brain
heart infusion broth 4 days in succession for maximal type
1-pilus expression, and stained for 1 min with 1% phospho-
tungstic acid (pH 7.0) on copper grids coated with Formvar
and carbon. The samples were examined in a JEOL 1200 SX
microscope.
Adhesion to cecal brush membranes. The assay of adhesion
to immobilized brush border membranes isolated from 2.5 x
106 epithelial cells has been described in detail previously
(47). All assays were performed in triplicate. Briefly, pre-
warmed 35S04-labeled E. coli cells (0.2 ml) were added to
wells containing immobilized brush borders. The plates were
incubated for 1 h at 37°C, and the wells were then washed
twice with HEPES-Hanks buffer (pH 7.4) to remove un-
bound bacteria. Adherent bacteria were released by adding
0.5 ml of 5% sodium dodecyl sulfate to each well and then
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FIG. 1. Electron micrographs of E. ccli F-18 (A), E. ccli F-18
FimA- (B), and E. ccli F-18 FimH- (C).
C~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
incubating the plates for 3 h at 370C. The sodium dodecyl
sulfate was removed from each well, and the level of
radioactivity was determined by scintillation counting.
Radioactive bacteria released less than 0.5% of the total
incorporated label during the 1-h incubation period. Further-
more, subsequent incubation of supernatants failed to pro-
duce significant levels of radioactivity adhering to epithelial
cells or brush borders (<250 cpm).
Adhesion to BSA glycoconjugates. (Mannose-ot-O-CETE),,-
BSA, hereafter called Man-BSA, and (CH
-0-CETE),,-BSA,
hereafter called CETE-BSA, were immobilized in polysty-
rene tissue culture wells as described previously (47) [CETE
is 2-(2-carbomethoxyethylthio)ethyl]. Adhesion assays using
35S04-labeled E. coli were then performed as described
above.
Media and antibiotics. L broth was made as described by
Revel (42). L agar is L broth containing 12 g of Bacto-Agar
(Difco Laboratories, Detroit, Mich.) per liter. MacConkey
agar (Difco) and brain heart infusion broth (Scott Laborato-
ries, Inc., Fiskeville, R.I.) were prepared according to
package instructions. Streptomycin sulfate, rifampin, tetra-
cycline hydrochloride, and kanamycin monosulfate were
purchased from Sigma Chemical Co., St. Louis, Mo.
Chemicals. All chemicals were reagent grade. Man-BSA
and CETE-BSA were purchased from Carbohydrates Inter-
national, Inc., Arlov, Sweden.
Statistics. When indicated in the text, means derived from
triplicate samples were compared by using Student's t test (P
values).
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TABLE 1. Adhesion of E. coli F-18 strains
Adhesion (cpm [mean ± SEI)a
Adhesion to: E. coli F-18 E. coli F-18
E. coli F-18 FimA FimH
Man-BSA 32,517 ± 781 5,270 + 704 4,920 ± 640
CETE-BSA 6,911 ± 737 6,013 ± 837 5,738 ± 151
Brush borders 17,151 ± 241 7,851 ± 764 5,267 ± 357
BSA 6,559 ± 131 8,528 ± 513 6,217 ± 450
a All adhesion assays were performed in triplicate. The specific activities of
the three strains were essentially identical at 6.0 x 10- cpm/CFU.
RESULTS
Electron microscopy ofE. coli F-18, E. coli F-18 FimA- and
E. coli F-18 FimH-. E. coli F-18 was bacteriophage P1
transduced with E. coli ORN151 (P1::Tn5) and E. coli
ORN133 (P1 clr 100 Cm) lysates. E. coli F-18 FimA- and E.
coli F-18 FimH- transductants were selected (see Materials
and Methods) and viewed by transmission electron micros-
copy (Fig. 1). Similarly, an E. coli F-18 Col- FimA- strain
selected by P1 transduction was viewed by transmission
electron microscopy (not shown). E. coli F-18 FimA- had no
pili (Fig. 1B), as reported previously forfimA mutants (22,
37), showing clearly that the pili observed on E. coli F-18
(Fig. 1A) were, in fact, type 1. Similarly, E. coli F-18 Col-
FimA- had no pili, showing that its pili (47) are also type 1.
Furthermore, pili were observed on E. coli F-18 FimH-
(Fig. 1C), as reported previously for E. coli K-12fimH (i.e,
adhesion-negative) mutants (24, 29).
Adhesion of the E. coli F-18 strains and the E. coli ORN
strains to Man-BSA and CETE-BSA. E. coli strains bearing
type 1 pili bind specifically to receptors containing mannose
(22, 37, 43), whereas type 1 pilus-negative (FimA-) and
pilus-positive but adhesin-negative (FimH-) mutants do not
(22, 37). To determine whether E. coli F-18, E. coli F-18
FimA-, and E. coli F-18 FimH- behaved as expected for
type 1-containing, type 1-negative, and adhesin-negative
strains, respectively, the E. coli F-18 strains and their E. coli
ORN counterparts were tested for their abilities to bind to
immobilized Man-BSA and CETE-BSA. As expected for
type 1 pilus-bearing strains, adhesion of E. coli F-18 (Table
1) to Man-BSA was about fourfold greater than to CETE-
BSA (P < 0.001) and adhesion of E. coli 0RN152 (Table 2)
to Man-BSA was about threefold greater than to CETE-BSA
(P < 0.001). Similarly, as expected for type 1 pilus-negative
and adhesin-negative strains, adhesion of E. coli F-18
FimA- and F-18 FimH- (Table 1) and E. coli ORN151
(FimA-) and ORN133 (FimH-) (Table 2) to Man-BSA and
CETE-BSA was about equal (P > 0.10 in each case); i.e., no
mannose specificity was observed.
Since the colonization model used in this study requires
treating mice with streptomycin, E. coli F-18 and E. coli F-18
TABLE 2. Adhesion of E. coli ORN strains
Adhesion (cpm [mean ± SE])'
Adhesion to: E. coli E. coli ORN151 E. coli ORN133
ORN152 (FimA-) (FimH-)
Man-BSA 22,752 ± 953 16,469 ± 418 5,823 ± 958
CETE-BSA 7,967 + 152 6,745 ± 267 5,350 ± 555
Brush borders 12,084 ± 116 4,434 ± 101 1,958 ± 24
BSA 7,019 ± 158 6,549 ± 239 5,531 ± 220
a All adhesion assays were performed in triplicate. The specific activities of
the three strains were essentially identical at 3.6 x 1O-3 cpm/CFU.
FimA- were grown in the presence of streptomycin sulfate
(100 jig per ml), examined Inicroscopically, and tested for
their abilities to bind to Man-BSA and CETE-BSA in both
the presence and absence of streptomycin sulfate (100 ,ug/
ml). The data-obtained were no different from those pre-
sented in Fig. 1 and Table 1; i.e., growing E. coli F-18 in
streptomycin did not affect type 1-pilus expression nor did
the presence of streptomycin alter type 1-pilus adhesive
function (data not shown).
Adhesion of the E. coli F-18 strains and the E. coli ORN
strains to cecal brush borders. Adhesion of E. coli F-18 to
immobilized cecal brush border membranes (Table 1) was
about two- and threefold greater than that of E. coli F-18
FimA- and E. coli F-18 FimH-, respectively, to immobi-
lized brush border membranes (P < 0.001 in each case).
These data suggest that E. coli F-18 type 1 pili bind specif-
ically to cecal brush border receptors and in doing so give E.
coli F-18 an advantage in binding relative to E. coli F-18
FimA- and E. coli F-18 FimH-. In addition, similar adhe-
sion experiments using the E. coli K-12 strains (Table 2)
showed that the type 1-piliated E. coli ORN152 bound
approximately three- and sixfold better to cecal brush border
membranes than did ORN151 (FimA-) and ORN133
(FimH-), respectively (P < 0.001 in each case). Also, the
presence of streptomycin sulfate (100 ,ug/ml) did not alter the
ability of E. coli F-18 to bind to cecal brush borders (data not
shown).
Relative colonizing abilities of E. coli F-18, E. coli F-18
FimA-, and E. coli F-18 FimH-. The system used to assess
the relative colonizing abilities of the E. coli strains tested is
a competitive streptomycin-treated mouse model. In this
model the normal mouse facultative gram-negative flora is
reduced and the relative numbers of the different anaerobic
flora are altered by streptomycin treatment (18, 32). Without
such treatment, exogenously introduced E. coli strains do
not colonize, but with streptomycin treatment, most E. coli
strains colonize indefinitely at about 107 CFU/g of feces
when fed to mice individually (33, 45). Therefore, we nor-
mally feed streptomycin-treated mice two nearly isogenic
streptomycin-resistant strains and continue streptomycin
treatment. If the two strains are equally fit in the intestine,
then both will colonize the large intestine equally well (i.e.,
both will persist in feces at between 106 and 107 CFU/g) (33).
However, if one strain has an advantage over the other, then
it will become the dominant organism and persist in feces
while the other strain will decrease in feces with time (6, 7,
33). With this in mind, streptomycin-treated mice were fed
either E. coli F-18 and E. coli F-18 FimA- (Fig. 2) or E. coli
F-18 and E. coli F-18 FimH- (Fig. 3). Under these condi-
tions both E. coli F-18 FimA- and E. coli F-18 FimH- were
as good colonizers as their parent, E. coli F-18. That is, each
strain colonized at between 106 and 107 CFU/g of feces
indefinitely (Fig. 2 and 3). Furthermore, when mice were fed
104 CFU each of E. coli F-18 and E. coli F-18 FimA- or 104
CFU each of E. coli F-18 and E. coli F-18 FimH- (instead of
1010 CFU), each strain grew equally well in vivo from 104
CFU/g of feces to between 107 and 108 CFU/g of feces within
48 h and colonized at that level indefinitely (data not shown).
These data suggest that at any dose E. coli F-18 FimA- and
E. coli FimH- colonize the streptomycin-treated mouse
large intestine as well as E. coli F-18.
E. coli F-18 and E. coli F-18 FimA- were also fed to
streptomycin-treated mice at 1010 CFU each and allowed to
colonize for 17 days. At that time, streptomycin treatment
was discontinued and the numbers of each strain in feces
were determined at 24-h intervals for the next 11 days.
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FIG. 2. Colonization by E. coli F-18 (0) and E. ccli F-18 FimAf
During that time, the numbers of both strains dropped from
iO' CFUIg of feces to i0' CFUIg of feces at identical rates
(data not shown), suggesting that streptomycin treatment did
not prevent E. ccli F-18 interactions in vivo which would
give it an advantage over E. coli F-18 FimA in untreated
mice.
Relative colonizing abilities of E. coli F-18 FimA-, E. coli
F-18 FimH-, and E. coli F-18 ColV. E. coli F-18 ColP is a far
worse colonizer of the streptomycin-treated mouse large
intestine than its parent, E. ccli F-18, because it grows
poorly in cecal mucus in the presence of E. ccli F-18 (46).
However, E. coli F-18 Col- does make type 1 pili and binds
specifically to Man-BSA (47). Therefore, to determine
whether type 1 pili confer an advantage to E. coli F-18 Col-,
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FIG. 3. Colonization by E. coli F-18 (0) and E. coli F-18 FimH-
(0).
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making it a better colonizer relative to the pilus-negative and
adhesin-negative strains than it is relative to E. coli F-18,
streptomycin-treated mice were fed either E. coli F-18
FimA- and E. coli F-18 Col- (Fig. 4) or E. ccli F-18 FimH-
and E. ccli F-18 Col- (Fig. 5). Both E. ccli F-18 FimA- and
E. ccli F-18 FimH-, like E. ccli F-18 (7, 46), were found to
be far better colonizers than E. ccli F-18 Col- (Fig. 4 and 5).
Relative colonizing abilities of the K-12 strains, E. coli
0RN152 and E. coli ORN151 (FimA-). Streptomycin-treated
mice were fed both the type 1-piliated E. ccli 0RN152 and
the nonpiliated F. ccli ORN151 (FimA-). The nonpiliated
strain colonized at about 106 CFU/g of feces, whereas the
LU
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FIG. 5. Colonization by E. coli F-18 FimH- (O) and E. coli F-18
Col- (0).
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FIG. 6. Colonization by E. coli ORN152 (0) and E. coli ORN151
(FimA-) (0).
type 1-piliated strain colonized at between 104 and 105
CFU/g of feces (Fig. 6).
DISCUSSION
The data presented here show that functional type 1 pili
are not necessary for E. coli F-18 to colonize the streptomy-
cin-treated mouse large intestine. That is, transduction of a
defective fimA gene into E. coli F-18 resulted in bald F-18
cells (Fig. 1B), proving that E. coli F-18 pili are indeed type
1; but colonizing ability was retained by E. coli F-18 FimA-
(Fig. 2) despite a twofold drop in its ability to bind to cecal
brush border membranes in vitro (Table 1). Furthermore, E.
coli F-18 FimH-, i.e., lacking the type 1 adhesin protein in
its pili (2, 3, 25), also retained the colonizing ability of its
parent (Fig. 3), despite a threefold drop in ability to bind to
cecal brush border membranes in vitro (Table 1). In addition,
the FimA- E. coli K-12 strain ORN151 colonized the strep-
tomycin-treated mouse large intestine at about an order of
magnitude better than its type 1-piliated counterpart,
ORN152 (Fig. 6), despite a threefold drop in ability to bind to
cecal brush border membranes in vitro (Table 2). We cannot
rule out the possibility that this difference reflects an effect of
the expression of the tetracycline resistance gene present in
ORN151 (FimA-) or the kanamycin resistance gene present
in ORN152 rather than a slight adverse effect of type 1 pilus
expression on the colonizing ability of E. coli ORN152. In
any case, these data again suggest that type 1 pili do not
increase large-intestine colonizing ability. These results are
in sharp contrast to the role type 1 pili appear to play in
ascending urinary tract infection of mouse and rat bladders
(4, 14, 17, 20, 21).
The data reported here do not rule out the possibility that
adhesion to cecal brush border membranes is important in
the ability of E. coli F-18 to colonize the streptomycin-
treated mouse large intestine. Human fecal E. coli strains
often make more than one adhesin (5, 11). Some E. coli
adhesin genes are on plasmids (11, 13, 15, 38, 40, 44), and
others, including those for type 1 pili, are on the chromo-
some (5, 15, 19, 26-28). Therefore, E. coli F-18, which
contains seven plasmids (7), may make one or more adhesins
other than type 1 pili in vivo that are not made in vitro. If so,
adhesion to cecal epithelial cells might still be important for
colonization in vivo; i.e., E. coli F-18 FimA- and E. coli
F-18 FimH- might both make epithelial cell-specific adhes-
ins in vivo which allow them to compete effectively with E.
coli F-18. However, while this may be a strong possibility for
E. coli F-18, it is a less likely, although still possible,
explanation as to why E. coli ORN152 and E. coli ORN151
(FimA-) colonize about equally well (Fig. 6). That is, K-12
strains are less likely to contain operons for additional
adhesins since they are plasmidless and their chromosomes
do not contain nucleotide sequences related to the pap, prs,
and afal operons, which encode chromosomal genes for
adhesins commonly found in uropathogenic E. coli strains
(34; Richard Goldstein, personal communication).
If E. coli F-18 and E. coli ORN152 make no other adhesin
in vivo, there are still other possibilities to explain why type
1 pili play no role in their ability to colonize the streptomy-
cin-treated mouse large intestine. For example, it is known
that transcription of the fimA gene is regulated by the
orientation of an invertable 300-base-pair DNA segment
which contains the fimA promoter (1, 12, 23, 36). If the
transcription-off orientation is favored in vivo, E. coli F-18
would have no type 1 pili in vivo and therefore no advantage
over E. coli F-18 FimA- and E. coli FimH-. Alternatively,
it is possible that E. coli F-18 expresses type 1 pili in vivo but
does not bind to mannose-containing receptors present in
epithelial cell border membranes because it binds first to
type 1-specific receptors present in cecal mucus (47). If so,
E. coli F-18, E. coli F-18 FimA-, and E. coli F-18 FimH-
might be identical in their abilities to grow in mucus, resist
washout, and colonize the large intestine. Specific receptors
for various E. coli and Salmonella typhimurium strains in
mucus have, in fact, been implicated in inhibiting adhesion
to epithelial cells (8, 9, 31). Experiments designed to test
whether E. coli F-18 expresses type 1 pili in vivo and, if so,
whether type 1-specific receptors present in cecal mucus
prevent E. coli F-18 from binding to cecal epithelial cells are
in progress.
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